Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Toremifene × Clear all

NCT00020735 2015-12-02

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms